Back to Search
Start Over
Optimizing Thiopurine Therapy with a Xanthine Oxidase Inhibitor in Patients with Systemic Autoimmune Diseases: A Single-Centre Experience.
- Source :
- Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière; Fall2021, Vol. 74 Issue 4, p361-369, 9p
- Publication Year :
- 2021
-
Abstract
- <i>Copyright of Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière is the property of Canadian Society of Hospital Pharmacists and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
- Subjects :
- XANTHINE oxidase
AUTOIMMUNE diseases
HEPATOTOXICOLOGY
ERYTHROCYTES
AZATHIOPRINE
Subjects
Details
- Language :
- English
- ISSN :
- 00084123
- Volume :
- 74
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière
- Publication Type :
- Academic Journal
- Accession number :
- 156610623
- Full Text :
- https://doi.org/10.4212/cjhp.v74i4.3199